¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Functional intestinal disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • hypoactive sexual desire disorder
    ¼º¿å°¨¼Òº´
  • hearing disorder
    µè±âÀå¾Ö, û·ÂÀå¾Ö
  • hematologic disorder
    Ç÷¾×Àå¾Ö
  • hemostatic disorder
    ÁöÇ÷Àå¾Ö, Ç÷¾×ÀÀ°íÀå¾Ö
  • hereditary coagulation disorder
    À¯ÀüÀÀ°íÀå¾Ö
  • hereditary disorder
    À¯ÀüÀå¾Ö, À¯ÀüÁúȯ
  • hormonal disorder
    È£¸£¸óÀå¾Ö, ³»ºÐºñÀå¾Ö
  • ion channel disorder
    ÀÌ¿ÂÅë·ÎÁúȯ
  • immune disorder
    ¸é¿ªÁúȯ, ¸é¿ªÀå¾Ö
  • immunoproliferative disorder
    ¸é¿ªÁõ½ÄÀå¾Ö
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • identity disorder
    Á¤Ã¼¼ºÀå¾Ö
  • intermittent explosive disorder
    °£ÇæÆø¹ßÀå¾Ö
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • identity disorder
    ÁÖü¼ºÀå¾Ö
  • immune disorder
    ¸é¿ªÁúȯ, ¸é¿ªÀå¾Ö
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
  • intermittent explosive disorder
    °£ÇæÆø¹ßÀå¾Ö, °£ÇæÆø¹ßº´
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • major affective disorder
    ÁÖ¿äÁ¤µ¿Àå¾Ö, ÁÖ¿äÁ¤µ¿º´
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö, Á¤½Åº´
  • metabolic disorder
    ´ë»çÀå¾Ö
  • micturition disorder
    ¹è´¢Àå¾Ö
  • minor depressive disorder
    °æÁõ¿ì¿ïÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • personality disorder, inadequate
    ºÎÀû°Ý¼º ÀΰÝÀå¾Ö
  • personality disorder, mixed type
    È¥ÀçÇü(ûèî¤úþ) ÀΰÝÀå¾Ö
  • personality disorder, multiple
    ´ÙÁß(Òýñì) ÀΰÝÀå¾Ö
  • personality disorder, narcissistic
    ÀÚ±â¾Ö¼º(í»Ðùäñàõ) ÀΰÝÀå¾Ö
  • personality disorder, negativistic
    ¹ÝÇ×¼º ÀΰÝÀå¾Ö
  • personality disorder, obsessional
    °­¹Ú¼º ÀΰÝÀå¾Ö
  • personality disorder, obsessive-compulsive
    °­¹Ú¼º ÀΰÝÀå¾Ö
  • personality disorder, paranoid
    ÆíÁý¼º(ø¶òûàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive
    ¼öµ¿¼º(áôÔÑàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality disorder, psychopathic
    Á¤½Åº´Áú(ïñãêÜ»òõ)¼º ÀΰÝÀå¾Ö
  • personality disorder, schizoid
    ºÐ¿­¼º(ÝÂæñàõ) ÀΰÝÀå¾Ö
  • personality disorder, schizotypal
    ºÐ¿­Çü ÀΰÝÀå¾Ö
  • personality disorder, self- defeating
    ÀÚ±âÆÐ¹è¼º(í»Ðùø¨ÛÅàõ) ÀΰÝÀå¾Ö
  • personality disorder, sociopathic
    »çȸº´Áú¼º(ÞäüåÜ»òõàõ) ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • intestinal obstruction
    ÀåÆó¼â(Áõ).
  • intestinal perforation
    Àåõ°ø.
  • intestinal peristalsis
    À忬µ¿(íóêãÔÑ).
  • intestinal phase
    Àå»ó(íóßÓ) ¡ìÀ§¾×ºÐºñ(êÖäûÝÂÝô)ÀÇ¡í.
  • intestinal polyp
    Àå(íó)Æú¸³.
  • intestinal polyposis
    ÀåÆú¸³Áõ.
  • intestinal portal
    Àå¹®(íóÚ¦).
  • intestinal protozoa
    Àå³»¿øÃæ
  • intestinal reflex
    Àå¹Ý»ç.
  • intestinal reflex
    Àå¹Ý»ç(íóÚãÞÒ).
  • intestinal relaxation
    ÀåÀÌ¿Ï.
  • intestinal replacement fluid
    À庸¾×.
  • intestinal resection
    ÀåÀýÁ¦(¼ú).
  • intestinal sound
    ÀåÀ½( ëå).
  • intestinal stenosis
    ÀåÇùÂø(Áõ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
VIP vasoactive intestinal peptide; vasoinhibitory peptide; venous impedance plethysmography; ventricular...
VIPoma vasoactive intestinal polypeptide-secreting tumor
FRC Functional Residual Capacity
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
AVNFRP atrioventricular node functional refractory period
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
IP Intestinal permeability
VmaxFRC Maximal flow at functional residual capacity
MMIHS Megacystis Microcolon Intestinal Hypoperistalsis Syndrome
Min Multiple Intestinal Neoplasia
NID Neuronal Intestinal Dysplasia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • painful muscle disorder
    ÅëÁõ¼º ±ÙÀ° Àå¾Ö
  • pancreatic disorder
    ÃéÀå Àå¾Ö
  • paraprotein-producing disorder
    ÆÄ¶ó ÇÁ·ÎÅ×ÀÎ »ý¼º Àå¾Ö
  • parathyroid gland disorder
    ºÎ°©»ó¼± ÀÌ»ó
  • perception disorder
    Áö°¢ Àå¾Ö
  • Peruvian wart :

    pervasive developmental disorder

    Àü¹ÝÀû ¹ß´Þ Àå¾Ö
    ¼Ò¾Æ, û¼Ò³â Á¤½Å Àå¾ÖÀÇ Çϳª·Î »óÈ£ »çȸÀû ¹ÝÀÀ, ¾ð¾î ¹× ºñ¾ð¾î¼º ±³Åë ±â¼ú ¹× »ó»ó·Â µîÀÇ ¹ß´Þ¿¡ °áÇÔÀÌ ÀÖ´Â °Í. ÀÚÆó Àå¾Öµµ ¿©±â¿¡ Æ÷ÇԵȴÙ.
  • polysubstance-related disorder
    º¹ÇÕ ¹°Áú °ü·Ã Àå¾Öº´
  • primary non-inflammatory, myogenous pain disorder
    ¿ø¹ß¼ºÀÇ ºñ¿°Áõ¼º ±ÙÀ° µ¿Åë Àå¾Ö
  • primary temporomandibular disorder
    ¿ø¹ß¼º ÃøµÎÇϾÇÀå¾Ö
  • pseudotumour :

    pseudounipolar bipolar III disorder

    °¡¼º ´Ü±Ø¼º ¾ç±Ø¼º III Àå¾Ö, °¡¼º ´Ü±Ø¼º ¾ç±Ø¼º III º´
  • psychiatric disorder
    Á¤½Å Àå¾Ö
  • psychoactive substance-induced organic mental disorder
    ȰÁ¤½Å¼º ¹°Áú·Î À¯µµµÈ ±âÁúÀû Á¤½Å Àå¾Ö
    ȰÁ¤½Å¼º ¹°ÁúÀÇ »ç¿ë°ú °ü·ÃµÈ ±âÁúÀû ³ú ÁõÈÄ. ¿­ °¡Áö Ư¼ö ÁõÈĸ¦ Æ÷ÇÔÇϰí Àִµ¥ Áßµ¶, Áß´Ü Áõ»ó, ¼¶¸Á, Ä¡¸Å, °Ç¸Á Àå¾Ö, ¸Á»ó Àå¾Ö, ȯ°¢, °¨Á¤ Àå¾Ö, Áö°¢ Àå¾Ö ¹× ÀÎ°Ý Àå¾Ö µîÀÌ´Ù. ¾ËÄÝ Áßµ¶°ú °°ÀÌ ¿øÀÎ ¹°ÁúÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸é À̸¦ ¸í±âÇÑ´Ù.
  • psychogenic pain disorder
    ½É¸®Àû ÅëÁõ Àå¾Ö, Á¤½ÅÀû ÅëÁõ Àå¾Ö, ½ÉÀμº ÅëÁõÀå¾Ö
    µ¿ÀǾî=
  • psychophysiology disorder
    Á¤½Å »ý¸® Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
chromosome disorder An abnormal condition due to an abnormality of the chromosomes. For example, Down syndrome (the genetic abnormality featuring three chromosome 21s, instead of two, also refered to as trisomy 21) is a chromosome disorder.
(12 Dec 1998)
rumination disorder A mental disorder occurring in infancy characterised by repeated regurgitation of food; usually accompanied by weight loss or failure to gain weight.
(05 Mar 2000)
cocaine-related disorder <psychiatry> Disorders related or resulting from use of cocaine.
(12 Dec 1998)
cognition disorder <psychology> Disturbances in the mental process related to thinking, reasoning, and judgment.
(12 Dec 1998)
compulsive personality disorder <psychology> A personality disorder which is characterised by the avoidance of feelings, emotion and intimacy within a framework of strict adherence to rules and order.
(05 Jan 1998)
conduct disorder A repetitive and persistent pattern of behaviour in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviours include aggressive conduct that causes or threatens physical harm to other people or animals, nonagressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18.
(12 Dec 1998)
multiple personality disorder A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behaviour patterns and social friendships. Transition from one personality to another is sudden.
(12 Dec 1998)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
polygenic disorder <genetics> Genetic disorders resulting from the combined action of alleles of more thanone gene (for example, heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single-gene disorders.
(14 Oct 1997)
posttraumatic stress disorder Development of characteristic symptoms following a psychologically traumatic event that is generally outside the range of usual human experience; symptoms include numbed responsiveness to environmental stimuli, a variety of autonomic and cognitive dysfunctions, and dysphoria.
(05 Mar 2000)
cyclothymic disorder An affective disorder characterised by periods of depression and hypomania. These may be separated by periods of normal mood.
(12 Dec 1998)
cyclothymic personality disorder A personality disorder in which a person experiences regularly alternating periods of elation and depression, (see bipolar illness) usually not related to external circumstances or situation.
(27 Sep 1997)
Hartnup disorder <biochemistry> Amino acid transport defect that leads to excessive loss of monoamino monocarboxylic acids (cystine, lysine, ornithine, arginine) in the urine and poor absorption in the gut.
See: iminoglycinuria.
(18 Nov 1997)
heat stress disorder A group of conditions due to overexposure to or overexertion in excess environmental temperature.
It includes heat cramps, which are non-emergent and treated by salt replacement; heat exhaustion, which is more serious, treated with fluid and salt replacement; and heatstroke, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á